Canada markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.57+0.44 (+4.40%)
At close: 04:00PM EDT
10.77 +0.20 (+1.89%)
After hours: 04:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 273.83M
Enterprise Value 158.75M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)281.70
Price/Book (mrq)2.33
Enterprise Value/Revenue 190.80
Enterprise Value/EBITDA -1.22

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 315.90%
S&P500 52-Week Change 322.36%
52 Week High 314.75
52 Week Low 33.84
50-Day Moving Average 310.48
200-Day Moving Average 36.82

Share Statistics

Avg Vol (3 month) 3475.15k
Avg Vol (10 day) 3366.59k
Shares Outstanding 525.91M
Implied Shares Outstanding 625.91M
Float 823.03M
% Held by Insiders 11.48%
% Held by Institutions 116.66%
Shares Short (Apr 15, 2024) 42.26M
Short Ratio (Apr 15, 2024) 45.55
Short % of Float (Apr 15, 2024) 49.76%
Short % of Shares Outstanding (Apr 15, 2024) 49.68%
Shares Short (prior month Mar 15, 2024) 42.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Jan 25, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-26,686.29%

Management Effectiveness

Return on Assets (ttm)-32.11%
Return on Equity (ttm)-79.55%

Income Statement

Revenue (ttm)832.01k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-17.70%
Gross Profit (ttm)N/A
EBITDA -130.66M
Net Income Avi to Common (ttm)-135.12M
Diluted EPS (ttm)-6.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)145.29M
Total Cash Per Share (mrq)6.22
Total Debt (mrq)30.21M
Total Debt/Equity (mrq)25.74%
Current Ratio (mrq)3.60
Book Value Per Share (mrq)5.15

Cash Flow Statement

Operating Cash Flow (ttm)-124.37M
Levered Free Cash Flow (ttm)-86.15M